Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in Belgium.

Rakan NasreddineJean Cyr YombiGilles DarcisEric FlorenceSabine D AllardMarie-Angélique De ScheerderSophie HenrardRémy DemeesterPeter MessiaenNathalie AusseletMatthias LoeckxMarc DelforgeStéphane De Witnull null

Published in: HIV medicine (2022)

In this real-world analysis, the 2DRs analysed were effective, durable, and safe for both treatment-naïve and treatment-experienced patients. A slight increase in weight was associated with these regimens.

Keyphrases

antiretroviral therapy
hiv infected patients
end stage renal disease
ejection fraction
hiv infected
chronic kidney disease
body mass index
hepatitis c virus
hiv positive
combination therapy
physical activity
hiv testing